Arlington Trust »

ResMed shares owned by Arlington Trust

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Arlington Trust from 13F filings

Historical chart of Arlington Trust investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Arlington Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Arlington Trust

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.6k 40 240.88
2025-09-30 $11k 40 273.73
2025-06-30 $10k 40 258.00
2025-03-31 $9.0k 40 223.85

More positions owned by Arlington Trust

Etf Opportunities Trust (AQEC)
Vanguard Total Stock Market ETF (VTI)
Vanguard High Dividend Yield ETF (VYM)
Vanguard Europe Pacific ETF (VEA)
Vanguard Dividend Appreciation ETF (VIG)
Vanguard Int High Dvd Yld In exchange traded funds (VYMI)
Invesco S&p 500 Equal Weight Etf (RSP)
Berkshire Hathaway (BRK.B)
iShares S&P 500 Value Index (IVE)
Proshares Tr russ 2000 divd (SMDV)
Apple (AAPL)
iShares S&P 500 Index (IVV)
Microsoft Corporation (MSFT)
iShares S&P MidCap 400 Index (IJH)
Vanguard S&p 500 Etf idx (VOO)

View all positions for Arlington Trust

Top funds holding ResMed

Vanguard Group
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Invesco
Northern Trust
First Trust Advisors
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Swedbank AB
Nordea Investment Management Ab
Norges Bank Investment Management
Legal & General Group
Dimensional Fund Advisors

View all funds holding ResMed